FI882891L - Förfarande för produktion av en angiogenisk faktor - Google Patents

Förfarande för produktion av en angiogenisk faktor Download PDF

Info

Publication number: FI882891L
Authority: FI; Finland
Prior art keywords: producing; angiogenic factor; angiogenic; factor
Prior art date: 1985-12-17

Application number

FI882891A

Other languages

English (en)

Finnish (fi)

Other versions

FI93843B (sv

FI882891A0 (sv

FI93843C (sv

Inventor

David A Moscatelli

Daniel B Rifkin

Andreas Sommer

Original Assignee

Synergen Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-12-17

Filing date

1988-06-16

Publication date

1988-06-16

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27420052&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI882891(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1988-06-16 Application filed by Synergen Inc filed Critical Synergen Inc

1988-06-16 Publication of FI882891A0 publication Critical patent/FI882891A0/sv

1988-06-16 Publication of FI882891L publication Critical patent/FI882891L/sv

1995-02-28 Publication of FI93843B publication Critical patent/FI93843B/sv

1995-06-12 Application granted granted Critical

1995-06-12 Publication of FI93843C publication Critical patent/FI93843C/sv

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/515—Angiogenesic factors; Angiogenin
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
- C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/035—Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Zoology (AREA)
Biomedical Technology (AREA)
Molecular Biology (AREA)
General Engineering & Computer Science (AREA)
Biochemistry (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Wood Science & Technology (AREA)
Biotechnology (AREA)
Biophysics (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Gastroenterology & Hepatology (AREA)
Cardiology (AREA)
Plant Pathology (AREA)
Microbiology (AREA)
Heart & Thoracic Surgery (AREA)
Vascular Medicine (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Physics & Mathematics (AREA)
Toxicology (AREA)
Urology & Nephrology (AREA)
Dermatology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Enzymes And Modification Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

FI882891A 1985-12-17 1988-06-16 Förfarande för produktion av en angiogenisk faktor FI93843C (sv)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US80987385A	1985-12-17	1985-12-17
US88855486A	1986-07-16	1986-07-16
US89582986A	1986-08-12	1986-08-12
PCT/US1986/002669 WO1987003885A1 (en)	1985-12-17	1986-12-12	Human placenta angiogenic factor capable of stimulating capillary endothelial cell protease synthesis, dna synthesis and migration

Publications (4)

Publication Number	Publication Date
FI882891A0 FI882891A0 (sv)	1988-06-16
FI882891L true FI882891L (sv)	1988-06-16
FI93843B FI93843B (sv)	1995-02-28
FI93843C FI93843C (sv)	1995-06-12

Family

ID=27420052

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI882891A FI93843C (sv)	1985-12-17	1988-06-16	Förfarande för produktion av en angiogenisk faktor

Country Status (15)

Country	Link
EP (1)	EP0226181B1 (sv)
JP (1)	JPH10262668A (sv)
KR (1)	KR960015442B1 (sv)
AT (1)	ATE107315T1 (sv)
AU (2)	AU6774887A (sv)
DE (1)	DE3689921T2 (sv)
DK (1)	DK424387D0 (sv)
ES (1)	ES2056787T3 (sv)
FI (1)	FI93843C (sv)
IE (1)	IE863281L (sv)
IL (1)	IL80944A (sv)
NO (1)	NO177859C (sv)
NZ (1)	NZ218631A (sv)
PT (1)	PT83939B (sv)
WO (1)	WO1987003885A1 (sv)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5852177A (en) *	1987-02-24	1998-12-22	Takeda Chemical Industries, Ltd.	Basic fibroblast growth factor (bFGF) muteins
US4900673A (en) *	1988-03-28	1990-02-13	President And Fellows Of Harvard College	Mutant human angiogenin (angiogenesis factor with superior angiogenin activity) genes therefor and methods of expression
CA2002261A1 (en) *	1988-11-07	1990-05-07	Andreas Sommer	High molecular weight human angiogenic factors
AU659723B2 (en) *	1992-02-14	1995-05-25	Kaken Pharmaceutical Co., Ltd.	Remedy for airway diseases
GB9203533D0 (en) *	1992-02-19	1992-04-08	Erba Carlo Spa	Use of the conjugate between a fibroblast growth factor and a saporin in treating ocular pathologies
US6749850B1 (en) *	1999-08-18	2004-06-15	The General Hospital Corporation	Methods, compositions and kits for promoting recovery from damage to the central nervous system
CA2488414C (en)	2002-06-18	2011-04-26	Eisai Co., Ltd.	Primary cultured adipocytes for gene therapy
ES2713062T3 (es) *	2005-09-27	2019-05-17	Tissuetech Inc	Preparaciones de membrana amniótica y composiciones purificadas y métodos de uso
CN111100191A (zh) *	2018-10-26	2020-05-05	神威药业集团有限公司	源于人胎盘的活性蛋白质或多肽及其用途
JP7516652B2 (ja) *	2020-07-16	2024-07-16	ケアジェンカンパニー，リミテッド	重症急性呼吸器症候群コロナウイルス２型に中和活性を有するペプチド

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4225670A (en) *	1978-12-29	1980-09-30	Monsanto Company	Production of tumor angiogenesis factor by cell culture
US4209587A (en) *	1978-12-29	1980-06-24	Monsanto Company	Production of tumor angiogenesis factor by cell culture
DE3110560A1 (de) *	1981-03-18	1982-10-14	Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen	"angiotropine der leukozyten und des entzuendungsgewebes: eine neue klasse natuerlicher chemotropischer mitogene fuer das richtungswachstum von blutgefaessen und zur neovaskularisierung von geweben"
US4529590A (en) *	1982-12-27	1985-07-16	Leveen Robert F	Production of angiogenetic factor
GB2146523B (en) *	1983-09-13	1987-01-07	Ward Page Faulk	Preparation for stimulating growth of blood vessels prepared from amniochorionic tissue and macrophages
JPH0789936B2 (ja) *	1985-09-12	1995-10-04	サイオスノバインコーポレイテッド	組換え繊維芽細胞成長因子
IL81650A0 (en) *	1986-02-24	1987-09-16	Robapharm Ag	Purified human angiogenic factor,method for its preparation and pharmaceutical preparations

1986
- 1986-12-11 AT AT86117257T patent/ATE107315T1/de not_active IP Right Cessation
- 1986-12-11 DE DE3689921T patent/DE3689921T2/de not_active Expired - Fee Related
- 1986-12-11 ES ES86117257T patent/ES2056787T3/es not_active Expired - Lifetime
- 1986-12-11 EP EP86117257A patent/EP0226181B1/en not_active Revoked
- 1986-12-11 IL IL8094486A patent/IL80944A/en not_active IP Right Cessation
- 1986-12-12 KR KR1019870700727A patent/KR960015442B1/ko not_active Expired - Fee Related
- 1986-12-12 WO PCT/US1986/002669 patent/WO1987003885A1/en not_active Ceased
- 1986-12-12 AU AU67748/87A patent/AU6774887A/en not_active Abandoned
- 1986-12-15 NZ NZ218631A patent/NZ218631A/en unknown
- 1986-12-16 IE IE863281A patent/IE863281L/xx not_active Application Discontinuation
- 1986-12-16 PT PT83939A patent/PT83939B/pt not_active IP Right Cessation
1987
- 1987-08-14 NO NO873437A patent/NO177859C/no unknown
- 1987-08-14 DK DK424387A patent/DK424387D0/da not_active Application Discontinuation
1988
- 1988-06-16 FI FI882891A patent/FI93843C/sv not_active IP Right Cessation
1991
- 1991-04-29 AU AU76299/91A patent/AU650649B2/en not_active Ceased
1998
- 1998-01-28 JP JP10015790A patent/JPH10262668A/ja active Pending

Also Published As

Publication number	Publication date
DE3689921T2 (de)	1994-09-22
ES2056787T3 (es)	1994-10-16
NZ218631A (en)	1991-07-26
KR960015442B1 (ko)	1996-11-14
PT83939A (en)	1987-01-01
ATE107315T1 (de)	1994-07-15
FI93843B (sv)	1995-02-28
DK424387A (da)	1987-08-14
DE3689921D1 (de)	1994-07-21
WO1987003885A1 (en)	1987-07-02
NO177859C (no)	1995-12-06
IL80944A (en)	1994-10-07
FI882891A0 (sv)	1988-06-16
FI93843C (sv)	1995-06-12
JPH10262668A (ja)	1998-10-06
KR880700820A (ko)	1988-04-12
DK424387D0 (da)	1987-08-14
AU650649B2 (en)	1994-06-30
EP0226181B1 (en)	1994-06-15
IE863281L (en)	1987-06-17
AU6774887A (en)	1987-07-15
IL80944A0 (en)	1987-03-31
NO873437D0 (no)	1987-08-14
NO177859B (no)	1995-08-28
AU7629991A (en)	1991-08-08
NO873437L (no)	1987-08-14
EP0226181A3 (en)	1989-03-08
PT83939B (pt)	1989-05-31
EP0226181A2 (en)	1987-06-24

Publication	Publication Date	Title
KR870700614A (ko)	1987-12-30	-1-아릴-2-아실아미도-3-플루오로-1-프로판올의 제조방법
ES552067A0 (es)	1987-04-16	Metodo para producir un preparado de etoposido
LV10866A (lv)	1995-10-20	Di-terc-butilfenola atvasinajumu iegusanas metode
BG49939A3 (bg)	1992-03-16	Метод за получаване на 2-анилино-пиримидинови производни
FI891711L (sv)	1989-12-26	Förfarande för framställning av diorganodialkoxisilaner
KR870700615A (ko)	1987-12-30	감마-부티로락톤의 제조방법
IT1182843B (it)	1987-10-05	Metodo di registrazione
PT87014A (pt)	1988-04-01	Method for producing ibuprofen
KR880700245A (ko)	1988-02-22	디지타이징 방법
FI883122L (sv)	1988-06-30	Framställningsförfarande av papper
KR860004922A (ko)	1986-07-16	N-포르밀-α-아스파르틸페닐알라닌의 제조방법
FI894005A7 (sv)	1990-04-13	Förfarande för koncentrering av lösningar
FI882891L (sv)	1988-06-16	Förfarande för produktion av en angiogenisk faktor
KR880700343A (ko)	1988-02-22	복합곡면 생성방법
KR860005834A (ko)	1986-08-13	N-보호된-α-L-아스파르틸-L-페닐알라닌 메틸 에스테르의 제조방법
FI891362A7 (sv)	1989-09-30	Förfarande för framställning av nya alkanofenoner
KR870001175A (ko)	1987-03-11	5-치환된-6-아미노피리미딘 유도체의 제조방법
DE3676753D1 (de)	1991-02-14	Stranggiessverfahren.
KR880700337A (ko)	1988-02-22	복합곡면 생성방법
FI915193A7 (sv)	1991-11-04	Sammanfogningsförfarande
FI870050L (sv)	1988-07-08	Förfarande för framställning av ett luktreduceringsmedel
KR880700336A (ko)	1988-02-22	복합곡면 생성방법
KR900702433A (ko)	1990-12-07	레퍼런스점 복귀방식
KR880700344A (ko)	1988-02-22	복합곡면 생성방법
KR860005779A (ko)	1986-08-13	부탄디카복실산 에스테르의 제조방법

Legal Events

Date	Code	Title	Description
1995-02-01	BB	Publication of examined application
1998-12-12	MM	Patent lapsed
2004-08-31	MM	Patent lapsed	Owner name: SYNERGEN, INC.